DOCSLIB.ORG

Scientific Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Scientific Program Scientific Program 1 he Annual Meeting of the Brazilian Biophysics Society, one of the largest T and most traditional gathering of Biophysicists in Latin America, occurs during the second semester of each year. Now in its 43rd edition, the 2018 meeting will be held again at the Mendes Plaza Hotel, in the city of Santos (SP), from September 27th to 30th. A rich program of 16 symposia, 4 plenary talks, and 2 poster sessions covering a broad range of topics in Biophysics will guarantee the appropriate environment for productive discussions about developments regarding Biophysics and its interfaces with Biochemistry, Medicine, Pharmacy, among other disciplines. World leaders in several areas of Biophysics, from at least 12 different countries have already confirmed participation in our meeting this year! We will host researchers from Argentina, Belgium, Canada, Denmark, England, France, Germany, Israel, Portugal, United States, Uruguay and, of course, from Brazil, which will be represented by colleagues from 10 different states. This shows our broad representation in both national and international scenarios. We believe our meeting is the perfect opportunity for researchers interested in Biophysics and related fields to present their latest results to a very distinguished audience. Therefore, we invite you to participate and to submit an abstract for the poster sessions. Looking forward to seeing you in Santos! Antonio Costa-Filho President of SBBf 2 3 Index Iseli L. Nantes Cardoso ................................................ 56 Tayana Mazin Tsubone ................................................. 83 Juliana S Yoneda ........................................................ 57 Yan M. H. Gonçalves ................................................... 84 Organizing Committee ............................................7 Katia Regina Perez ....................................................... 33 Lucas Rodrigues de Mello............................................ 57 Yeny Y. P. Valencia ..................................................... 84 Scientific Committee ..............................................7 Maria Elena de Lima .................................................... 33 Lucivaldo R. Menezes .................................................. 58 Virginia Sara Grancieri do Amaral ................................. 85 Sponsors ................................................................7 SY8 - Photobiology and its application Mario de Oliveira Neto ................................................. 58 Biomembranes .....................................................86 Congress Venue......................................................8 in Health Sciences................................................35 Maurício S. Baptista .................................................... 59 Ana Paula R. Povinelli .................................................. 86 Criação e diagramção: ...........................................8 Renato E. de Araujo ..................................................... 35 Rafael G. Carvalho....................................................... 59 Anacleto Silva de Souza ............................................... 86 Program .................................................................9 Yoshimura, T. M. ......................................................... 35 Rhiannon W. Harries .................................................... 59 Anderson F. Sepulveda ................................................. 86 Plenary Lectures .................................................. 13 Tayana Tsubone .......................................................... 36 Vinicius Carrascosa ..................................................... 60 Balan, A. ..................................................................... 87 Gronenborn, A. M. ....................................................... 14 João Paulo Tardivo ...................................................... 36 Biomedical Application .........................................61 Aryane A. Vigato ......................................................... 87 Benoît Roux ............................................................... 14 Beate Röder ................................................................ 37 Raissa L. Oblitas ........................................................ 61 Raphael Dias de Castro ............................................... 88 Aníbal E. Vercesi ......................................................... 14 SY9 - Structural and Unstructural Biology ............38 André L.S. Santos ....................................................... 61 Amantino C. F ............................................................. 88 J. A. Bouwstra ............................................................ 15 Garegin A. Papoian ...................................................... 38 Angela D. B. de Brito .................................................. 62 Lígia N. M. Ribeiro ....................................................... 89 Vladimir N. Uversky ..................................................... 38 Camila Ramos Silva .................................................... 62 Fabiana V. Diasa .......................................................... 89 Pre-symposium .................................................... 16 Yraima Cordeiro .......................................................... 38 Catarina Cataldi ........................................................... 63 Franciele Garcia Baveloni ............................................. 90 PSY1 - Sirius and the new opportunities Pinheiro, Glaucia M.S. ................................................. 39 Débora C. K. Codognato .............................................. 63 Gabriel Zazeri .............................................................. 90 in biophysics ........................................................17 SY10 - Biophysics of the heart .............................40 Cilli, E. M. ................................................................... 64 Gianella Facchin1 ........................................................ 90 Carla Polo ................................................................... 17 Danilo Roman Campos ................................................ 40 Cabral, F. V .................................................................. 64 Giovana Firpo .............................................................. 91 Ana Carolina de Mattos Zeri ......................................... 17 Rosana A. Bassani ...................................................... 40 Haroldo de Lima P. Cravo ............................................. 65 Gonçalves G. E. G ...................................................... 91 Maria Cristina Nonato .................................................. 18 Micaela Lopez Alarcón ................................................ 41 Juliana Guerra Pinto .................................................... 65 Isabele Ap. S. de Campos ............................................ 92 Emiliano Medei ............................................................ 41 Letícia Corrêa Fontana ................................................. 66 João Hermínio Martins da Silva ................................... 92 Symposium .......................................................... 19 SY11 - Methods in Biophysics ..............................42 L. M. Rebelo ............................................................... 66 Juliana Damasceno Oliveira ......................................... 93 SY1 - Cell and model membranes Biophysics .......20 Paul C. Whitford .......................................................... 42 Luciana Maria Cortez Marcolino .................................. 66 Kelli Cristina Freitas Mariano ........................................ 94 Adriana Fontes ........................................................... 20 Marin van Heel ............................................................ 42 Natalia K. Gushiken ..................................................... 67 Larissa D. da Silva....................................................... 94 Koji Kinoshita .............................................................. 20 Fabio Cesar Gozzo ...................................................... 42 Nayara S. Alcântara Contessoto ................................... 67 Luciana Guimarães Munhoz ......................................... 95 Nuno C. Santos ........................................................... 20 Roberto K. Salinas ...................................................... 43 Nicole M. A. Chaparro ................................................ 68 Matheus P. Pinheiro ..................................................... 95 Luis A. Bagatolli .......................................................... 21 SY12 - Nanostructures .........................................44 Sa. Arsalani................................................................. 68 Mayk C. Ramos ........................................................... 96 SY2 - Central Nervous System Electrophysiology .... 22 Alan B. Dalton ............................................................. 44 Soudabeh. Arsalani ..................................................... 69 Mayra C. G. Lotierzo ................................................... 96 Leonardo Cirqueira ..................................................... 22 Leandro Ramos Souza Barbosa ................................... 44 Taline S. Almeida ......................................................... 69 Nascimento M. H. M ...................................................
Load more

Recommended publications
  • The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections
    toxins Review The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections Patience Shumba 1, Srikanth Mairpady Shambat 2 and Nikolai Siemens 1,* 1 Center for Functional Genomics of Microbes, Department of Molecular Genetics and Infection Biology, University of Greifswald, D-17489 Greifswald, Germany; [email protected] 2 Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +49-3834-420-5711 Received: 20 May 2019; Accepted: 10 June 2019; Published: 11 June 2019 Abstract: Necrotizing soft tissue infections (NSTIs) are critical clinical conditions characterized by extensive necrosis of any layer of the soft tissue and systemic toxicity. Group A streptococci (GAS) and Staphylococcus aureus are two major pathogens associated with monomicrobial NSTIs. In the tissue environment, both Gram-positive bacteria secrete a variety of molecules, including pore-forming exotoxins, superantigens, and proteases with cytolytic and immunomodulatory functions. The present review summarizes the current knowledge about streptococcal and staphylococcal toxins in NSTIs with a special focus on their contribution to disease progression, tissue pathology, and immune evasion strategies. Keywords: Streptococcus pyogenes; group A streptococcus; Staphylococcus aureus; skin infections; necrotizing soft tissue infections; pore-forming toxins; superantigens; immunomodulatory proteases; immune responses Key Contribution: Group A streptococcal and Staphylococcus aureus toxins manipulate host physiological and immunological responses to promote disease severity and progression. 1. Introduction Necrotizing soft tissue infections (NSTIs) are rare and represent a more severe rapidly progressing form of soft tissue infections that account for significant morbidity and mortality [1].
    [Show full text]
  • Corynebacterium Diphtheriae Strains Correlates with the Predicted Membrane- Associated and Secreted Proteome Vartul Sangal1*, Jochen Blom2, Iain C
    Sangal et al. BMC Genomics (2015) 16:765 DOI 10.1186/s12864-015-1980-8 RESEARCH ARTICLE Open Access Adherence and invasive properties of Corynebacterium diphtheriae strains correlates with the predicted membrane- associated and secreted proteome Vartul Sangal1*, Jochen Blom2, Iain C. Sutcliffe1, Christina von Hunolstein3, Andreas Burkovski4 and Paul A. Hoskisson5 Abstract Background: Non-toxigenic Corynebacterium diphtheriae strains are emerging as a major cause of severe pharyngitis and tonsillitis as well as invasive diseases such as endocarditis, septic arthritis, splenic abscesses and osteomyelitis. C. diphtheriae strains have been reported to vary in their ability to adhere and invade different cell lines. To identify the genetic basis of variation in the degrees of pathogenicity, we sequenced the genomes of four strains of C. diphtheriae (ISS 3319, ISS 4060, ISS 4746 and ISS 4749) that are well characterised in terms of their ability to adhere and invade mammalian cells. Results: Comparative analyses of 20 C. diphtheriae genome sequences, including 16 publicly available genomes, revealed a pan-genome comprising 3,989 protein coding sequences that include 1,625 core genes and 2,364 accessory genes. Most of the genomic variation between these strains relates to uncharacterised genes encoding hypothetical proteins or transposases. Further analyses of protein sequences using an array of bioinformatic tools predicted most of the accessory proteome to be located in the cytoplasm. The membrane-associated and secreted proteins are generally involved in adhesion and virulence characteristics. The genes encoding membrane-associated proteins, especially the number and organisation of the pilus gene clusters (spa) including the number of genes encoding surface proteins with LPXTG motifs differed between different strains.
    [Show full text]
  • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
    toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases.
    [Show full text]
  • Report from the 26Th Meeting on Toxinology,“Bioengineering Of
    toxins Meeting Report Report from the 26th Meeting on Toxinology, “Bioengineering of Toxins”, Organized by the French Society of Toxinology (SFET) and Held in Paris, France, 4–5 December 2019 Pascale Marchot 1,* , Sylvie Diochot 2, Michel R. Popoff 3 and Evelyne Benoit 4 1 Laboratoire ‘Architecture et Fonction des Macromolécules Biologiques’, CNRS/Aix-Marseille Université, Faculté des Sciences-Campus Luminy, 13288 Marseille CEDEX 09, France 2 Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d’Azur, CNRS, Sophia Antipolis, 06550 Valbonne, France; [email protected] 3 Bacterial Toxins, Institut Pasteur, 75015 Paris, France; michel-robert.popoff@pasteur.fr 4 Service d’Ingénierie Moléculaire des Protéines (SIMOPRO), CEA de Saclay, Université Paris-Saclay, 91191 Gif-sur-Yvette, France; [email protected] * Correspondence: [email protected]; Tel.: +33-4-9182-5579 Received: 18 December 2019; Accepted: 27 December 2019; Published: 3 January 2020 1. Preface This 26th edition of the annual Meeting on Toxinology (RT26) of the SFET (http://sfet.asso.fr/ international) was held at the Institut Pasteur of Paris on 4–5 December 2019. The central theme selected for this meeting, “Bioengineering of Toxins”, gave rise to two thematic sessions: one on animal and plant toxins (one of our “core” themes), and a second one on bacterial toxins in honour of Dr. Michel R. Popoff (Institut Pasteur, Paris, France), both sessions being aimed at emphasizing the latest findings on their respective topics. Nine speakers from eight countries (Belgium, Denmark, France, Germany, Russia, Singapore, the United Kingdom, and the United States of America) were invited as international experts to present their work, and other researchers and students presented theirs through 23 shorter lectures and 27 posters.
    [Show full text]
  • The Buzz About ADP-Ribosylation Toxins from Paenibacillus Larvae, the Causative Agent of American Foulbrood in Honey Bees
    toxins Review The Buzz about ADP-Ribosylation Toxins from Paenibacillus larvae, the Causative Agent of American Foulbrood in Honey Bees Julia Ebeling 1 , Anne Fünfhaus 1 and Elke Genersch 1,2,* 1 Department of Molecular Microbiology and Bee Diseases, Institute for Bee Research, 16540 Hohen Neuendorf, Germany; [email protected] (J.E.); [email protected] (A.F.) 2 Department of Veterinary Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, 14163 Berlin, Germany * Correspondence: [email protected]; Tel.: +49-3303-293833 Abstract: The Gram-positive, spore-forming bacterium Paenibacillus larvae is the etiological agent of American Foulbrood, a highly contagious and often fatal honey bee brood disease. The species P. lar- vae comprises five so-called ERIC-genotypes which differ in virulence and pathogenesis strategies. In the past two decades, the identification and characterization of several P. larvae virulence factors have led to considerable progress in understanding the molecular basis of pathogen-host-interactions during P. larvae infections. Among these virulence factors are three ADP-ribosylating AB-toxins, Plx1, Plx2, and C3larvin. Plx1 is a phage-born toxin highly homologous to the pierisin-like AB-toxins expressed by the whites-and-yellows family Pieridae (Lepidoptera, Insecta) and to scabin expressed by the plant pathogen Streptomyces scabiei. These toxins ADP-ribosylate DNA and thus induce apoptosis. While the presumed cellular target of Plx1 still awaits final experimental proof, the classification of the A subunits of the binary AB-toxins Plx2 and C3larvin as typical C3-like toxins, which ADP-ribosylate Rho-proteins, has been confirmed experimentally.
    [Show full text]
  • Instability of Toxin a Subunit of AB5 Toxins in the Bacterial Periplasm Caused by Deficiency of Their Cognate B Subunits
    Biochimica et Biophysica Acta 1808 (2011) 2359–2365 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem Instability of toxin A subunit of AB5 toxins in the bacterial periplasm caused by deficiency of their cognate B subunits Sang-Hyun Kim a, Su Hyang Ryu a, Sang-Ho Lee a, Yong-Hoon Lee a, Sang-Rae Lee a, Jae-Won Huh a, Sun-Uk Kim a, Ekyune Kim d, Sunghyun Kim b, Sangyong Jon b, Russell E. Bishop c,⁎, Kyu-Tae Chang a,⁎⁎ a The National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Chungbuk 363–883, Republic of Korea b School of Life Science, Gwangju Institute of Science and Technology (GIST), 1 Oryong-dong, Gwangju 500–712, Republic of Korea c Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 d College of Pharmacy, Catholic University of Daegu, Hayang-eup, Gyeongsan, Gyeongbuk 712-702, Republic of Korea article info abstract Article history: Shiga toxin (STx) belongs to the AB5 toxin family and is transiently localized in the periplasm before secretion Received 26 April 2011 into the extracellular milieu. While producing outer membrane vesicles (OMVs) containing only A subunit of Received in revised form 3 June 2011 the toxin (STxA), we created specific STx1B- and STx2B-deficient mutants of E. coli O157:H7. Surprisingly, Accepted 23 June 2011 STxA subunit was absent in the OMVs and periplasm of the STxB-deficient mutants. In parallel, the A subunit Available online 5 July 2011 of heat-labile toxin (LT) of enterotoxigenic E.
    [Show full text]
  • Mycotoxin Analysis in Infant Formula Using Captiva EMR-Lipid
    Application Note Food Testing & Agriculture Mycotoxin Analysis in Infant Formula Using Captiva EMR—Lipid Cleanup and LC/MS/MS Author Abstract Derick Lucas Agilent Technologies, Inc. Several countries regulate the levels of mycotoxins in foods. However, the complexity of certain foodstuffs in terms of protein and lipid content can prove challenging in the accurate quantitation of low-level mycotoxins in these matrices. This Application Note describes the determination of 13 multiclass mycotoxins in solid and liquid infant formulations using a Quick Easy Cheap Effective Rugged Safe (QuEChERS) workflow followed by Agilent Captiva EMR—Lipid cartridge cleanup. Due to the high selectivity of the Captiva EMR—Lipid sorbent, excellent recoveries (70.4 to 106.8 %) and precision (<18 %) were achieved for all mycotoxins. This simple and robust methodology requires minimal equipment and expertise, which promotes easy implementation in food laboratories. Introduction Experimental Mycotoxins are produced as secondary metabolites by fungal Sample preparation species that grow on various crops such as grain, corn, and • Captiva EMR—Lipid 3-mL tubes (p/n 5190-1003) nuts. When cows ingest contaminated feed, mycotoxins and their metabolites can be excreted into the animal’s milk1. • Captiva EMR—Lipid 6-mL tubes (p/n 5190-1004) Aflatoxin M1 is the most commonly found mycotoxin in milk, • QuEChERS original extraction salts (p/n 5982-5550) and is monitored and regulated in many countries, including • VacElut SPS 24 vacuum manifold (p/n 12234022) the United States and European countries2,3. Despite a lack of regulations for other mycotoxins in milk, there is a growing LC configuration and parameters interest to monitor additional mycotoxins such as fumonisins and ochratoxins.
    [Show full text]
  • Impact of Bacterial Toxins in the Lungs
    toxins Review Impact of Bacterial Toxins in the Lungs 1,2,3, , 4,5, 3 2 Rudolf Lucas * y, Yalda Hadizamani y, Joyce Gonzales , Boris Gorshkov , Thomas Bodmer 6, Yves Berthiaume 7, Ueli Moehrlen 8, Hartmut Lode 9, Hanno Huwer 10, Martina Hudel 11, Mobarak Abu Mraheil 11, Haroldo Alfredo Flores Toque 1,2, 11 4,5,12,13, , Trinad Chakraborty and Jürg Hamacher * y 1 Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; hfl[email protected] 2 Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 3 Department of Medicine and Division of Pulmonary Critical Care Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 4 Lungen-und Atmungsstiftung, Bern, 3012 Bern, Switzerland; [email protected] 5 Pneumology, Clinic for General Internal Medicine, Lindenhofspital Bern, 3012 Bern, Switzerland 6 Labormedizinisches Zentrum Dr. Risch, Waldeggstr. 37 CH-3097 Liebefeld, Switzerland; [email protected] 7 Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; [email protected] 8 Pediatric Surgery, University Children’s Hospital, Zürich, Steinwiesstrasse 75, CH-8032 Zürch, Switzerland; [email protected] 9 Insitut für klinische Pharmakologie, Charité, Universitätsklinikum Berlin, Reichsstrasse 2, D-14052 Berlin, Germany; [email protected] 10 Department of Cardiothoracic Surgery, Voelklingen Heart Center, 66333
    [Show full text]
  • Identifying the Virulent Factors of Clostridium Perfringens Locally Isolated from Different Species
    2020, Scienceline Publication World’s Veterinary Journal World Vet J, 10(4): 617-624, December 25, 2020 ISSN 2322-4568 DOI: https://dx.doi.org/10.29252/scil.2020.wvj74 Identifying the Virulent Factors of Clostridium perfringens Locally Isolated from Different Species El-Helw, H. A.*¹, Taha, M. M.¹, Elham F. El-Sergany¹, Ebtesam, E.Z. Kotb², Hussein, A. S.¹, and Abdalla, Y. A.¹ ¹Veterinary Serum and Vaccine Research Institute, Agriculture Research Center, Abbasia, Cairo, Postcode: 11381, Egypt. ²Animal Reproduction Research Institute, Agriculture Research Center, El-Haram, Giza, Postcode:12619, Egypt. *Corresponding author’s Email: [email protected]; : 0000-0003-2851-9632 Accepted: Accepted: Received: pii:S23224568 OR ABSTRACT I Clostridium perfringens incriminated in many diseases among different species of animals due to its ability to ARTICLE GINAL produce many virulence factors. In the current study, 135 intestinal samples were collected from different animal 07 species of different localities in Egypt. Samples were subjected to isolation and identification (morphologically and 22 Nov Dec biochemically) for obtaining Clostridium perfringens isolates (n=26, 19.25%). The PCR was carried out to elucidate 20 000 the virulence factors. It was indicated that all the 26 Clostridium perfringens isolates had CPA gene and Clostridium 20 20 20 perfringens enterotoxin (CPE gene), whereas 23% of isolates of chicken and cattle intestinal samples contained 20 74 CPA, Net B, and CPE genes as virulence factors. Consequently, those isolates are highly recommended to be used in - the preparation of enterotoxemia and necrotic enteritis vaccines as they are more virulent strains. 10 Keywords: Clostridium perfringens, CPA gene, CPE gene, Net B gene INTRODUCTION Clostridium perfringens (C.
    [Show full text]
  • Mycotoxins in Plant Pathogenesis National Center for [\Nr!T'nihi,T,~L Utiiization Research P Peoria R Aw,,§\.YL) Anne E
    MPMI Vol. 10, No.2, 1997, pp. 147-152. Publication no. M-1997-0109-01O. "".II :-,• nV 8·. Current Review Supplied by U.S. Dept. of Agriculture Mycotoxins in Plant Pathogenesis National Center for [\nr!t'nihi,t,~l Utiiization Research p Peoria r aW,,§\.YL) Anne E. Desjardins1 and Thomas M. Hohn2 lBioactive Agents Research and 2Mycotoxin Research, National Center for Agricultural Utilization Research, USDAIARS, 1815 N. University Street, Peoria IL 61604 U.S.A. Received 11 November 1996. Accepted 13 December 1996. The study of fungal toxins in plant pathogenesis has made Mycotoxins are defined as low molecular weight fungal remarkable progress within the last decade. Prior to the mid metabolites that are toxic to vertebrates. Mycotoxins can have 1980s there was indeed a long history of research on fungal dramatic adverse effects on the health of farm animals and toxins. Fungal cultures provided a bewildering array of low humans that eat contaminated agricultural products. Myco­ molecular weight metabolites that demonstrated toxicity to toxicology has not been a traditional field of plant pathologi­ plants. But although it was easy to demonstrate that fungal cal research. Mycotoxin research has historically been per­ cultures contained toxic substances, it proved far more diffi­ formed by natural product chemists, mycologists, animal cult to establish their causal role in plant disease (Yoder toxicologists, and human disease epidemiologists. The appar­ 1980). Critical analysis of the role of toxins in pathogenesis ent lack of specificity of mycotoxins has hindered the accep­ had to wait for the development of laboratory methods to spe­ tance of a role for mycotoxins in plant pathogenesis.
    [Show full text]
  • Staphylococcal Enterotoxins: Molecular Aspects and Detection Methods
    Journal of Public Health and Epidemiology Vol. 2(3), pp. 29-42, June 2010 Available online at http://www.academicjournals.org/jphe ISSN 2141-2316 © 2010 Academic Journals Full Length Research Paper Staphylococcal enterotoxins: Molecular aspects and detection methods Nathalie Gaebler Vasconcelos and Maria de Lourdes Ribeiro de Souza da Cunha* Biosciences Institute, UNESP – Univ Estadual Paulista, Department of Microbiology and Immunology, Bacteriology Laboratory, Botucatu-SP, Brazil. Accepted 19 April, 2010 Members of the Staphylococcus genus, especially Staphylococcus aureus , are the most common pathogens found in hospitals and in community-acquired infections. Some of their pathogenicity is associated with enzyme and toxin production. Until recently, S. aureus was the most studied species in the genus; however, in last few years, the rise of infections caused by coagulase-negative staphylococci has pointed out the need for further studies on virulence factors that have not yet been completely elucidated so as to better characterize the pathogenic potential of this group of microorganisms. Several staphylococcal species produce enterotoxins, a family of related proteins responsible for many diseases, such as the toxic-shock syndrome, septicemia and food poisoning. To this date, 23 different enterotoxin types have been identified besides toxic-shock syndrome toxin-1 (TSST-1), and they can be divided into five phylogenetic groups. The mechanism of action of these toxins includes superantigen activity and emetic properties, which can lead to biological effects of infection. Various methods can detect genes that encode enterotoxins and their production. Molecular methods are the most frequently used at present. This review article has the objective to describe aspects related to the classification, structure and regulation of enterotoxins and toxic-shock syndrome toxin-1 detection methods.
    [Show full text]
  • Whole-Genome Characterization of Hemolytic Uremic Syndrome-Causing Shiga Toxin-Producing Escherichia Coli in Sweden
    Virulence ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/kvir20 Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden Ying Hua, Milan Chromek, Anne Frykman, Cecilia Jernberg, Valya Georgieva, Sverker Hansson, Ji Zhang, Ann Katrine Marits, Chengsong Wan, Andreas Matussek & Xiangning Bai To cite this article: Ying Hua, Milan Chromek, Anne Frykman, Cecilia Jernberg, Valya Georgieva, Sverker Hansson, Ji Zhang, Ann Katrine Marits, Chengsong Wan, Andreas Matussek & Xiangning Bai (2021) Whole-genome characterization of hemolytic uremic syndrome- causing Shiga toxin-producing Escherichiacoli in Sweden, Virulence, 12:1, 1296-1305, DOI: 10.1080/21505594.2021.1922010 To link to this article: https://doi.org/10.1080/21505594.2021.1922010 © 2021 The Author(s). Published by Informa View supplementary material UK Limited, trading as Taylor & Francis Group. Published online: 03 May 2021. Submit your article to this journal View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=kvir20 VIRULENCE 2021, VOL. 12, NO. 1, 1296–1305 https://doi.org/10.1080/21505594.2021.1922010 RESEARCH PAPER Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden Ying Huaa,b, Milan Chromekc, Anne Frykmand,e, Cecilia Jernberg f, Valya Georgievac, Sverker Hanssond,e, Ji Zhangg, Ann Katrine Maritsc, Chengsong Wana, Andreas
    [Show full text]